Vivien Hébert (V Hébert, V Hebert)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Capillary Electrophoresis

Juvenile Idiopathic Arthritis

Newly Diagnosed

Top Venues

The British journal of dermatology

Clinical and experimental dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Vivien Hébert, Pascal Joly
Major improvement of very severe alopecia aerata in patients treated with the combination of baricitinib and low doses of corticosteroids: an 8-case series. Clinical and experimental dermatology (2023)
Marie Petit, Marie-Laure Walet-Balieu, Damien Schapman, Marie-Laure Golinski, Carole Burel, Marion Barray, Laurent Drouot, Maud Maho-Vaillant, Vivien Hébert, Olivier Boyer, Muriel Bardor, Pascal Joly, Sébastien Calbo
Longitudinal Pathogenic Properties and N-Glycosylation Profile of Antibodies from Patients with Pemphigus after Corticosteroid Treatment. Biomedicines 9 (10) (2021)
Vivien Hébert, S Bastos, K Drenovska, J Meijer, Saskia Ingen Housz Oro, Christophe Bedane, L Lunardon, Sébastien Debarbieux, H Jedlickova, F Caux, Guillaume Chaby, Michel D'Incan, Claudio Feliciani, C Boulard, N Schumacher, E Schmidt, A Roussel, M A Richard, J Gottlieb, V Ferranti, O Guérin, J Bénichou, P Joly, null null
International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg-1 per day starting dose of oral corticosteroids to treat bullous pemphigoid. The British journal of dermatology (2021)
W Masmoudi, M Vaillant, S Vassileva, A Patsatsi, G Quereux, C Moltrasio, C Abasq, C Prost-Squarcioni, D Kottler, D Kiritsi, N Litrowski, P Plantin, L Friedrichsen, A Zebrowska, S Duvert-Lehembre, S Hofmann, V Ferranti, F Jouen, P Joly, Vivien Hébert, null null
International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid. The British journal of dermatology 184 (6) (2020)
Vivien Hébert, T Vermeulin, L Tanguy, B Tedbirt, C Mignard, J Bénichou, P Joly
Comparison of real costs in the French healthcare system in newly diagnosed patients with pemphigus for first-line treatment with rituximab vs. standard corticosteroid regimen: data from a national multicentre trial. The British journal of dermatology 183 (1) (2020)
L Ferries, A Gillibert, S Duvert-Lehembre, C Corbaux, M Alexandre, Catherine Prost-Squarcioni, F Caux, E Delaporte, N Litrowski, C Boulard, Dedee Frances Murrell, P Joly, Vivien Hébert
Sensitivity to change and correlation between the autoimmune bullous disease quality-of-life questionnaires ABQOL and TABQOL, and objective severity scores. The British journal of dermatology 183 (5) (2020)